Skip to main content
SpringerLink
Log in

Stereotactic Radiosurgery and Interstitial Brachytherapy for Glial Neoplasms

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The application of focal radiation therapies in the management of malignant gliomas has gone through a number of stages. Earlier efforts to improve local control of malignant gliomas involved the use of brachytherapy. Despite some early encouraging results, Phase 3 studies did not prove a significant survival benefit for the addition of brachytherapy for newly diagnosed glioblastoma. Most recently radiosurgery has been employed using the same rationale in that improved local control may improve survival. Results of the RTOG Phase 3 study are pending final publication, but early abstracted reports are negative. While radiosurgery and brachytherapy continue to be used as a form of therapy for selected patients with recurrent gliomas, new information from metabolic imaging studies suggests our problem with these techniques in part may be related to targeting. This paper reviews the recent literature and results of the use of brachytherapy and radiosurgery in the management of newly diagnosed and recurrent malignant gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bernstein M, Gutin PH: Interstitial irradiation of brain tumors: a review. Neurosurgery 9: 741–750, 1981

    CAS  PubMed  Google Scholar 

  2. Frazier C: The Effects of Rdium emanations upon brain tumors. Surg Gynecol Obstet 31: 236–239, 1920

    Google Scholar 

  3. Gutin PH, Prados MD, Phillips TL, et al.: External irradiation followed by an interstitial high activity iodine-125 implant ‘boost’ in the initial treatment of malignant gliomas: NCOG study 6G–82–2. Int J Radiat Oncol Biol Phys 21: 601–606, 1991

    CAS  PubMed  Google Scholar 

  4. McDermott MW, Sneed PK, Gutin PH: Interstitial brachytherapy for malignant brain tumors. Semin Surg Oncol 14: 79–87, 1998

    CAS  PubMed  Google Scholar 

  5. Prados MD, Gutin PH, Phillips TL, et al.: Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience. Int J Radiat Oncol Biol Phys 24: 593–597, 1992

    CAS  PubMed  Google Scholar 

  6. Scharfen CO, Sneed PK, Wara WM, et al.: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24: 583–591, 1992

    CAS  PubMed  Google Scholar 

  7. Sneed PK, Lamborn KR, Larson DA, et al.: Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 35: 37–44, 1996

    CAS  PubMed  Google Scholar 

  8. Sneed PK, Stauffer PR, McDermott MW, et al.: Survival bene t of hyperthermia in a prospective randomized trial of brachytherapy boost +/)hyperthermia for glioblas-toma multiforme. Int J Radiat Oncol Biol Phys 40: 287–295, 1998

    CAS  PubMed  Google Scholar 

  9. Florell RC, Macdonald DR, Irish WD, et al.: Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76: 179–183, 1992

    CAS  PubMed  Google Scholar 

  10. Laperriere NJ, Leung PM, McKenzie S, et al.: Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41: 1005–1011, 1998

    CAS  PubMed  Google Scholar 

  11. Selker RG, Shapiro WR, Burger P, et al.: The Brain Tumor Cooperative Group NIH Trial 87–01: a randomized comparison of surgery, external radiotherapy, and carmustine vs. surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51: 343–355;discussion 355–347, 2002

    PubMed  Google Scholar 

  12. Larson DA, Suplica JM, Chang SM, et al.: Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro-Oncology 6: in press

  13. Chamberlain MC, Barba D, Kormanik P, et al.: Stereotactic radiosurgery for recurrent gliomas. Cancer 74: 1342–1347, 1994

    CAS  PubMed  Google Scholar 

  14. Dunbar SF, Tarbell NJ, Kooy HM, et al.: Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. Int J Radiat Oncol Biol Phys 30: 531–539, 1994

    CAS  PubMed  Google Scholar 

  15. Gannett D, Stea B, Lulu B, et al.: Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 33: 461–468, 1995

    CAS  PubMed  Google Scholar 

  16. Hall WA, Djalilian HR, Sperduto PW, et al.: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13: 1642–1648, 1995

    CAS  PubMed  Google Scholar 

  17. Larson DA, Gutin PH, Leibel SA, et al.: Stereotaxic irradiation of brain tumors. Cancer 65: 792–799, 1990

    CAS  PubMed  Google Scholar 

  18. Larson DA, Gutin PH, McDermott M, et al.: Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys 36: 1045–1053, 1996

    CAS  PubMed  Google Scholar 

  19. Loeffler JS, Alexander E, 3rd, Shea WM, et al.: Radio-surgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 10: 1379–1385, 1992

    CAS  PubMed  Google Scholar 

  20. Loeffer JS, Shrieve DC, Alexander E, 3rd: Radiosurgery for glioblastoma multiforme: the importance of selection criteria. Int J Radiat Oncol Biol Phys 30: 731–733, 1994

    PubMed  Google Scholar 

  21. Masciopinto JE, Levin AB, Mehta MP, et al.: Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 82: 530–535, 1995

    CAS  PubMed  Google Scholar 

  22. McDermott MW, Sneed P, Chang S, et al.: Results of Radiosurgery for recurrent malignant gliomas, in Kondziolka D (ed): Radiosurgery 1995. Vol. 1, Karger, Basel 1996, pp 102–112

    Google Scholar 

  23. Sarkaria JN, Mehta MP, Loeffer JS, et al.: Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32: 931–941, 1995

    CAS  PubMed  Google Scholar 

  24. Shaw E, Scott C, Souhami L, et al.: Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90–05). Int J Radiat Oncol Biol Phys 34: 647–654, 1996

    CAS  PubMed  Google Scholar 

  25. Shrieve DC, Alexander E, 3rd, Black PM, et al.: Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90: 72–77, 1999

    CAS  PubMed  Google Scholar 

  26. Shrieve DC, Alexander E, 3rd, Wen PY, et al.: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36: 275–282;discussion 282–274, 1995

    CAS  PubMed  Google Scholar 

  27. Souhami L, Scott C, Brachman D, et al.: Randomized prospective comparison of stereotactic radiosurgery (SRS) followed by conventional radiotherapy (RT)with BCNU alone for selected patients with supratentorial glioblastoma multiforme (GBM): report of RTOG 93–05 Protocol. IJROBP 54(Suppl): 94–95, 2002

    Google Scholar 

  28. Barker FG, 2nd, Prados MD, Chang SM, et al.: Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 84: 442–448, 1996

    PubMed  Google Scholar 

  29. Graves EE, Nelson SJ, Vigneron DB, et al.: A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 46: 319–326;discussion 326–318, 2000

    CAS  PubMed  Google Scholar 

  30. Larson DA, Prados M, Lamborn KR, et al.: Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys 54: 1397–1404, 2002

    PubMed  Google Scholar 

  31. Graves EE, Nelson SJ, Vigneron DB, et al.: Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol 22: 613–624, 2001

    CAS  PubMed  Google Scholar 

  32. Levivier M, Wikier D, Goldman S, et al.: Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note. J Neurosurg 93(Suppl 3): 233–238, 2000

    PubMed  Google Scholar 

  33. Levivier M, Wikler D Jr, Massager N, et al.: The integration of metabolic imaging in stereotactic procedures including radiosurgery: a review. J Neurosurg 97: 542–550, 2002

    Google Scholar 

  34. Nelson SJ, Graves E, Pirzkall A, et al.: In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 16: 464–476, 2002

    PubMed  Google Scholar 

  35. Kondziolka D, Lunsford LD, Witt TC, et al.: The future of radiosurgery: radiobiology, technology, and applications. Surg Neurol 54: 406–414, 2000

    CAS  PubMed  Google Scholar 

  36. McDermott MW, Gutin PH, Berger MS, et al.: Interstitial and intracavitary irradiation of brain tumors. In: Winn HR (ed) Neurological Surgery. Vol. 4, Elsevier, Philadelphia, 2003, pp 4095–4109

    Google Scholar 

  37. Krishnaswamy V: Dose distribution around an 125I seed source in tissue. Radiology 126: 489–491, 1978

    CAS  PubMed  Google Scholar 

  38. Dempsey JF, Williams JA, Stubbs JB, et al.: Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of malignant brain-tumor resection-cavity margins. Int J Radiat Oncol Biol Phys 42: 421–429, 1998

    CAS  PubMed  Google Scholar 

  39. Tatter SB, Shaw EG, Rosenblum ML, et al.: An inffatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System)for treatment of recurrent malignant glioma: multicenter safety and feasibility trial. J Neurosurg 99: 297–303, 2003

    PubMed  Google Scholar 

  40. Gutin PH, Bernstein M: Stereotactic interstitial brachytherapy for malignant brain tumors. Prog Exp Tumor Res 28: 166–182, 1984

    CAS  PubMed  Google Scholar 

  41. Armour EP, Wang ZH, Corry PM, et al.: Sensitization of rat 9L gliosarcoma cells to low dose rate irradiation by long duration 41 degrees C hyperthermia. Cancer Res 51: 3088–3095, 1991

    CAS  PubMed  Google Scholar 

  42. Fowler JF: Why shorter half-times of repair lead to greater damage in pulsed brachytherapy. Int J Radiat Oncol Biol Phys 26: 353–356, 1993

    CAS  PubMed  Google Scholar 

  43. Fu KK, Phillips TL, Kane LJ, et al.: Tumor and normal tissue response to irradiation in vivo: variation with decreasing dose rates. Radiology 114: 709–716, 1975

    CAS  PubMed  Google Scholar 

  44. Hall EJ: The promise of low dose rate: has it been realized? Int J Radiat Oncol Biol Phys 4: 749–750, 1978

    CAS  PubMed  Google Scholar 

  45. Hall EJ: Radiation dose-rate: a factor of importance in radiobiology and radiotherapy. Br J Radiol 45: 81–97, 1972

    CAS  PubMed  Google Scholar 

  46. Ling CC, Spiro IJ, Mitchell J, et al.: The variation of OER with dose rate. Int J Radiat Oncol Biol Phys 11: 1367–1373, 1985

    CAS  PubMed  Google Scholar 

  47. Schultz CJ, Geard CR: Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. Int J Radiat Oncol Biol Phys 19: 1397–1403, 1990

    CAS  PubMed  Google Scholar 

  48. Arbit E, Shapiro JR, Fiola M, et al.: The significance of morphologically viable glioma cells found at the time of operation after interstitial brachytherapy. Neurosurgery 32: 105–110, 1993

    CAS  PubMed  Google Scholar 

  49. Ling CC, Chui CS: Stereotactic treatment of brain tumors with radioactive implants or external photon beams: radiobiophysical aspects. Radiother Oncol 26: 11–18, 1993

    CAS  PubMed  Google Scholar 

  50. Knox SJ, Sutherland W, Goris ML: Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase block and other radiobiological parameters. Radiat Res 135: 24–31, 1993

    CAS  PubMed  Google Scholar 

  51. Backlund EO: Colloidal radioisotopes as part of a multi-modality treatment of craniopharyngiomas. J Neurosurg Sci 33: 95–97, 1989

    CAS  PubMed  Google Scholar 

  52. Backlund EO, Axelsson B, Bergstrand CG, et al.: Treatment of craniopharyngiomas-the stereotactic approach in a ten to twenty-three years’ perspective. I. Surgical, radiological and ophthalmological aspects. Acta Neurochir (Wien)99: 11–19, 1989

    CAS  Google Scholar 

  53. Coffey RJ, Lunsford LD: The role of stereotactic techniques in the management of craniopharyngiomas. Neurosurg Clin N Am 1: 161–172, 1990

    CAS  PubMed  Google Scholar 

  54. Fig LM, Shapiro B, Taren J: Distribution of [32P]-chromic phosphate colloid in cystic brain tumors. Stereotact Funct Neurosurg 59: 166–168, 1992

    CAS  PubMed  Google Scholar 

  55. Adler JR Jr, Chang SD, Murphy MJ, et al.: The Cyberknife: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg 69: 124–128, 1997

    PubMed  Google Scholar 

  56. Loeffer JS, Siddon RL, Wen PY, et al.: Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects. Radiother Oncol 17: 311–321, 1990

    PubMed  Google Scholar 

  57. Schultz CJ, Gillin M, Mueller WM: Modi ed linear accelerator radiosurgery: principles and techniques. In: Germano IM (ed) Linac and Gamma Knife Radiosurgery. American Association of Neurological Surgeons, Park Ridge, 2000, pp 19–30

    Google Scholar 

  58. Loeffer J, Singer RJ, Chapman PH, et al.: Proton-beam radiation therapy. In: Germano IM (ed) Linac and Gamma Knife Radiosurgery. American Association of Neurological Surgeons, Park Ridge, 2000, pp 71–74

    Google Scholar 

  59. Yamamoto M: Gamma Knife radiosurgery: technology, applications and future directions. Neurosurg Clin N Am 10: 181–202, 1999

    CAS  PubMed  Google Scholar 

  60. Shaw E, Scott C, Souhami L, et al.: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 47: 291–298, 2000

    CAS  PubMed  Google Scholar 

  61. Larson DA, Flickinger JC, Loeffler JS: The radiobiology of radiosurgery. Int J Radiat Oncol Biol Phys 25: 557–561, 1993

    CAS  PubMed  Google Scholar 

  62. Curran WJ Jr, Scott CB, Weinstein AS, et al.: Survival comparison of radiosurgery-eligible and-ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: ta report of Radiation Therapy Oncology Group 83–02. J Clin Oncol 11: 857–862, 1993

    PubMed  Google Scholar 

  63. Haines SJ: Moving targets and ghosts of the past: outcome measurement in brain tumour therapy. J Clin Neurosci 9: 109–112, 2002

    PubMed  Google Scholar 

  64. Videtic GM, Gaspar LE, Zamorano L, et al.: Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys 45: 687–692, 1999

    CAS  PubMed  Google Scholar 

  65. Sneed PK, Prados MD, McDermott MW, et al.: Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 36: 898–903; discussion 903–894, 1995

    CAS  PubMed  Google Scholar 

  66. Sneed PK, Larson DA, Gutin PH: Brachytherapy and hyperthermia for malignant astrocytomas. Semin Oncol 21: 186–197, 1994

    CAS  PubMed  Google Scholar 

  67. Bampoe J, Laperriere N, Pintilie M, et al.: Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment. J Neurosurg 93: 917–926, 2000

    CAS  PubMed  Google Scholar 

  68. Gaspar LE, Zamorano LJ, Shamsa F, et al.: Permanent 125iodine implants for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 43: 977–982, 1999

    CAS  PubMed  Google Scholar 

  69. Halligan JB, Stelzer KJ, Rostomily RC, et al.: Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas. Int J Radiat Oncol Biol Phys 35: 541–547, 1996

    CAS  PubMed  Google Scholar 

  70. Patel S, Breneman JC, Warnick RE, et al.: Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme. Neurosurgery 46: 1123–1128; discussion 1128–1130, 2000

    CAS  PubMed  Google Scholar 

  71. Videtic GM, Gaspar LE, Zamorano L, et al.: Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys 51: 963–968, 2001

    CAS  PubMed  Google Scholar 

  72. Buatti JM, Friedman WA, Bova FJ, et al.: Linac radiosurgery for high-grade gliomas: the University of Florida experience. Int J Radiat Oncol Biol Phys 32: 205–210, 1995

    CAS  PubMed  Google Scholar 

  73. Mehta MP, Masciopinto J, Rozental J, et al.: Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 30: 541–549, 1994

    CAS  PubMed  Google Scholar 

  74. Kondziolka D, Flickinger JC, Bissonette DJ, et al.: Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41: 776–783; discussion 783–775, 1997

    CAS  PubMed  Google Scholar 

  75. Nwokedi EC, DiBiase SJ, Jabbour S, et al.: Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 50: 41–46;discussion 46–47, 2002

    PubMed  Google Scholar 

  76. Boethius J, Ulfarsson E, Rahn T, et al.: Gamma knife radiosurgery for pilocytic astrocytomas. J Neurosurg 97: 677–680, 2002

    PubMed  Google Scholar 

  77. Hadjipanayis CG, Kondziolka D, Gardner P, et al.: Stereotactic radiosurgery for pilocytic astrocytomas when multimodal therapy is necessary. J Neurosurg 97: 56–64, 2002

    PubMed  Google Scholar 

  78. Bernstein M, Laperriere N, Glen J, et al.: Brachytherapy for recurrent malignant astrocytoma. Int J Radiat Oncol Biol Phys 30: 1213–1217, 1994

    CAS  PubMed  Google Scholar 

  79. Chamberlain MC, Barba D, Kormanik P, et al.: Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors. Arch Neurol 52: 162–167, 1995

    CAS  PubMed  Google Scholar 

  80. Coffey RJ, Friedman WA: Interstitial brachytherapy of malignant brain tumors using computed tomography-guided stereotaxis and available imaging software: technical report. Neurosurgery 20: 4–7, 1987

    CAS  PubMed  Google Scholar 

  81. Leibel SA, Gutin PH, Wara WM, et al.: Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17: 1129–1139, 1989

    CAS  PubMed  Google Scholar 

  82. Loeffler JS, Alexander E, 3rd, Hochberg FH, et al.: Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 19: 1455–1462, 1990

    CAS  PubMed  Google Scholar 

  83. Loeffler JS, Alexander E, 3rd, Wen PY, et al.: Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst 82: 1918–1921, 1990

    CAS  PubMed  Google Scholar 

  84. McDermott MW, Gutin PH, Larson DA, et al.: Interstitial brachytherapy. Neurosurg Clin N Am 1: 801–824, 1990

    CAS  PubMed  Google Scholar 

  85. Sneed PK, Gutin PH, Prados MD, et al.: Brachytherapy of brain tumors. Stereotact Funct Neurosurg 59: 157–165, 1992

    CAS  PubMed  Google Scholar 

  86. Sneed PK, Russo C, Scharfen CO, et al.: Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors. Pediatr Neurosurg 24: 314–322, 1996

    CAS  PubMed  Google Scholar 

  87. Simon JM, Cornu P, Boisserie G, et al.: Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume. Int J Radiat Oncol Biol Phys 53: 67–74, 2002

    PubMed  Google Scholar 

  88. Sarkar A, Pollock BE, Brown PD, et al.: Evaluation of gamma knife radiosurgery in the treatment of oligoden-drogliomas and mixed oligodendroastrocytomas. J Neurosurg 97: 653–656, 2002

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of California, San Francisco, CA, USA

    M.W. McDermott, M.S. Berger & David A. Larson

  2. Department of Radiation Oncology, University of California, San Francisco, CA, USA

    M.W. McDermott, P.K. Sneed & David A. Larson

Authors
  1. M.W. McDermott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.S. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandeep Kunwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrew T. Parsa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P.K. Sneed
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David A. Larson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McDermott, M., Berger, M., Kunwar, S. et al. Stereotactic Radiosurgery and Interstitial Brachytherapy for Glial Neoplasms. J Neurooncol 69, 83–100 (2004). https://doi.org/10.1023/B:NEON.0000041873.42938.13

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:NEON.0000041873.42938.13

Search

Navigation